NPS Pharma (NPSP) Establishes Distribution Network for Gattex
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cramer Makes Solid Call on NPS Pharma (NPSP) into Gattex PDUFA
December 21, 2012 1:05 PM ESTNPS Pharmaceuticals (Nasdaq: NPSP) is back in positive territory today following some volatility earlier on an announcement that it received FDA approval for its Gattex (Teduglutide [rDNA origin]) for Injection. The drug will be approved for subcutaneous use for the treatment of adult... More
NPS Pharma (NPSP) Receives FDA Approval for Gattex
December 21, 2012 12:11 PM ESTNPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced that the U.S. Food and Drug Administration (FDA) has approved Gattex (Teduglutide [rDNA origin]) for Injection, for subcutaneous use for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on parenteral support.... More
FDA approves NPS Pharmaceuticals' (NPSP) Gattex
December 21, 2012 11:55 AM ESTFDA approves NPS Pharmaceuticals' (NASDAQ: NPSP) Gattex... More
